Clinical Trials Browser

Phase 1/2 × NIH × Anastrozole × Clear all

NCT00217399 2014-05-28

Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer

Phase 1/2 Completed

35 enrolled 9 charts

Breast Neoplasms